January 2019 - BiomolBiomed Viewpoints

March 28, 2023

Latest posts

[ March 2, 2023 ] The Reviewer of the Month for March 2023: Ognjen Barcot Reviewer of the month
[ February 14, 2023 ] BiomolBiomed’s Countdown: Most Cited and Most Shared Paper Awards 2023 News
[ February 13, 2023 ] Hematopathology Course on Lymphoma, March 31-April 1 (Izmir, Turkey) News
[ February 3, 2023 ] The Reviewer of the Month for February 2023: Dr. Chris Labaki Reviewer of the month
[ January 25, 2023 ] More than 1000 experts reviewed BJBMS manuscripts in 2022 News

Researchers found EZH2 overexpression to be an indicator of poor prognosis in synovial sarcomas

January 21, 2019 0

Synovial sarcoma (SS) is a rare malignant tumor of the young adults, usually located in deep-soft tissue. It is rare, but unfortunately fatal. The peak incidence is at 15-40 years of age, and affects mostly […]

Scientist report phenibut withdrawal to affect central nervous system receptors

January 9, 2019 0

Phenibut is a medication prescribed in former Communist Block countries to treat anxiety and other psychiatric disorders. It can be obtained in Western Countries as a dietary supplement, but is thought to have abuse potential. […]

BiomolBiomed Viewpoints

Science in plain words

Month: January 2019

Researchers found EZH2 overexpression to be an indicator of poor prognosis in synovial sarcomas

Scientist report phenibut withdrawal to affect central nervous system receptors

What matters the most when choosing the journal to submit your article?